Mereo BioPharma (MREO) Interest Coverage Ratio (2023 - 2026)

Mereo BioPharma (MREO) has reported Interest Coverage Ratio for 4 consecutive years, with 439.38 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Interest Coverage Ratio changed 0.44% year-over-year to 439.38 in Q2 2026; TTM through Jun 2026 was 393.11, a 690.49% decrease from a year earlier, with the FY2025 full-year figure at 157.28, down 354.94% from the prior year.
• Interest Coverage Ratio was 439.38 for Q2 2026 at Mereo BioPharma, roughly flat from 438.3 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 0.79 in Q2 2023 and troughed at 439.38 in Q2 2026.
• A 4-year average of 163.28 and a median of 39.72 in 2024 frame the typical range for Interest Coverage Ratio.
• Across the five-year window, Interest Coverage Ratio slumped 4811.92% in 2024 and decreased 0.44% in 2026, its largest moves.
• Over 4 years, Interest Coverage Ratio stood at 20.19 in 2023, then tumbled by 101.72% to 40.73 in 2024, then sank by 795.54% to 364.78 in 2025, then fell by 20.45% to 439.38 in 2026.
• The last three Interest Coverage Ratio figures came in at 439.38 (Q2 2026), 438.3 (Q1 2026), and 364.78 (Q4 2025), per Business Quant data.